Independent GLP-1 newsroomUpdated August 2026

The 5-minute GLP-1 briefing — prices, shortages, and provider moves.

A plain-English desk tracking what GLP-1 telehealth actually costs this week, what's in supply, and which providers earn our six-factor Brief Score. 509 providers here.

● The Desk's #1 pick · August 2026

CoreAge Rx tops the ranking — $99/mo semaglutide, $149/mo tirzepatide.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Best for: Readers who want a price they can plan around — no teaser-rate reset, no surprise membership fee, both molecules on one account.

CoreAge Rx

94 · A

Semaglutide: $99/mo
Tirzepatide: $149/mo
Coverage: All 50 states
Access: Compounded

Visit CoreAge Rx Read the CoreAge Rx review →

Advertising disclosure · we may earn a commission at no extra cost to you. It never changes a Brief Score. It does decide order: desks we earn on are listed first — see our disclosure.

What's on the desk

Five ways to use this desk

509 providers tracked · 45 sourced research pieces · 157 primary-source citations.

The ranking

Every desk, ranked

Brief Score across six factors — price stability, supply, transparency, access, oversight, track record.

Open →

This week

The price tracker

Headline monthly rates and which way they moved since our last check, so you know if today's price holds.

Open →

Head-to-head

Compare providers

Any two desks, factor by factor, plus a cost calculator to see the exact disclosed line for your molecule.

Open →

The evidence

Sourced research

Trials, dosing, cost, and safety — every clinical claim tied to PubMed or an FDA label, never gestured at.

Open →

Every desk

Provider briefs

The full index — pricing, pros, cons, and a Brief Score for every telehealth provider we track.

Open →

Latest briefs

All briefs →

This week in GLP-1

The price tracker

Headline monthly compounded prices at our tracked desks, with the direction each moved since our last check. A falling line is good news for you; rising is worth a second look.

Provider	Semaglutide	Tirzepatide	Trend	Desk note
CoreAge Rx	$99/mo	$149/mo	Stableprice stable	Flat rate held for a third straight cycle — no first-month teaser to reset.
Trimi	$175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge)	$235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge)	Stableprice stable	Membership rate held flat this cycle — both molecules disclosed up front, no first-month teaser.
Eden FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.	$239/mo	$349/mo	Stableprice stable	Premium line steady; high supply-chain disclosure keeps our confidence high.
Sesame Care	Care $59/mo only on the 12-month prepay, otherwise $99 billed every 28 days (13 charges a year) — plus the drug: brand Wegovy pill from $149/mo at 1.5 and 4 mg only, $299/mo at 9 and 25 mg	Care $59/mo on the 12-month prepay, otherwise $99 per 28 days — plus the drug: brand Zepbound vial $299/mo (2.5 mg), $399 (5 mg), $449 (7.5–15 mg); KwikPen $299 / $399 / $499 / $699 (10–15 mg)	Stableprice stable	Marketplace pricing is set per provider rather than one desk rate; the brand-name Wegovy pill line held its ~$149 entry this cycle.
ShedRx	$199/mo	$299/mo	Fallingprice falling	Competitive tirzepatide rate trimmed further this cycle — cheapest tirz among our partner desks.
Sprout Health FDA warning letter, September 2025 — issued to Sprout Health Partners LLC dba Sprout Health. See the FDA's warning letter database.	$299/mo	$349/mo	Stableprice stable	The standing compounded rates are $299 semaglutide / $349 tirzepatide; the $149/$199 on the home page are first-month-only prices under code FIRST150. A brand-name Wegovy/Zepbound path is available on the same account.
HealthRX	$190/mo month-to-month ($99 first month, renews at $165) · $99/mo on a 12-month prepay ($1,188)	$239/mo month-to-month ($149 first month, renews at $214) · $179/mo on a 12-month prepay ($2,148)	Stableprice stable	Company-stated tiers held flat this cycle; the LegitScript badge and a rare oral GLP tablet are the draw, but some tiers are self-reported rather than checkout-verified.
MadeMed	$239/mo injectable · $219/mo sublingual (quarterly)	$399/mo injectable · $299/mo sublingual (quarterly)	Stableprice stable	Publishes one price per route that holds at every dose — the cleanest dose-to-price mapping we track.
Invigor Medical	$199/mo	$339/mo	Stableprice stable	Long-running operator; mid-market pricing unchanged this cycle.
Telos Rx	$99/mo injectable — the $49 is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks	$139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide)	Stableprice stable	The $49 and $99 headlines are FIRST-MONTH rates on prepaid oral plans, not annual-lock rates: Telos itself labels them "first month", renewing at $129 and $139, and bills in 4/12/24/48-week cycles rather than calendar months. Standing injectable rates are $99 semaglutide and $139 tirzepatide; everything outside GLP-1 stays unpriced until intake.
Enhance MD	$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay	$329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay	Stableprice stable	The ladder is fully published, but its rungs are prepay blocks: $212 and $280 are the 12-MONTH rates, while month-to-month is $249 and $329 — and every plan bills every 4 weeks, so a "monthly" plan is 13 charges a year. The $112 is $212 less a dated SUMMER50 coupon, not an entry rate.
REMEVi	$219/mo (all doses, compounded)	$319/mo (all doses, compounded)	Newnew to the tracker, no prior reading	New to the tracker on 1 August 2026, and read on the provider's own site rather than taken on trust: we checked https://remevihealth.com/pricing on 2026-08-01 and this row reflects what that page says. The line we publish is $219/mo (all doses, compounded). There is no earlier reading of ours to compare it against yet.
Ro	Not disclosed	Not disclosed	Stableprice stable	Brand-name access and insurance navigation, but compounded pricing stays off the record.
Ondra Health	$93/mo	$166/mo	Stableprice stable	$93 sema / $166 tirz — the lowest accredited nationwide line we track; brand access + LegitScript.
Vaylen	$179/mo	$239/mo	Stableprice stable	$179 sema / $239 tirz; brand + oral + LegitScript across all 50 states.
Vytora Health	$150/mo	$200/mo	Stableprice stable	$150 sema / $200 tirz nationwide; LegitScript-certified with brand-name access.
yourEra	$199/mo	$299/mo	Stableprice stable	$199 sema / $299 tirz posted openly on-site; mid-market, but the number is right there before the quiz.
Strut Health FDA warning letter, February 2026 — issued to Strut Health, LLC dba Strut. See the FDA's warning letter database.	$99/mo lozenge · $149/mo injectable (auto-refill)	$199/mo lozenge · $199/mo injectable (auto-refill)	Stableprice stable	Cheapest oral route we track at $99 — but only on auto-refill; the one-off rate runs higher.
Effecty	$160/mo	$240/mo	Stableprice stable	$160 sema / $240 tirz; LegitScript-certified with brand-name access nationwide.
NiceRx	$199/mo	$299/mo	Stableprice stable	$199 sema / $299 tirz nationwide; LegitScript-certified, established operator.
Curex FDA warning letter, September 2025 — issued to Curex. See the FDA's warning letter database.	$199/mo	$199/mo	Stableprice stable	Flat $199 on both molecules; LegitScript-certified and nationwide.
Amazon One Medical	Not disclosed	Not disclosed	Stableprice stable	Brand-access model through One Medical clinicians; compounded pricing isn't published, so there's no sticker to track.
AgelessRx	$139/mo	Not disclosed	Stableprice stable	Low tracked semaglutide sticker; tirzepatide price still undisclosed.
Precision Telemed	$149/mo	$199/mo	Stableprice stable	$149 sema / $199 tirz nationwide; LegitScript-certified.
BetterMe Rx	$199/mo	$299/mo	Stableprice stable	$199 sema / $299 tirz held at the mid-market line; LegitScript-certified.

Prices reflect each desk's public disclosures at last check (August 2026) and change often — confirm on the provider's own site. Not medical advice.

Shortage status

Semaglutide (brand)In supply

Off the FDA shortage list; brand supply resolved.

Tirzepatide (brand)In supply

Off the FDA shortage list since late 2024.

Compounded supplyWatch

Legal but under ongoing FDA scrutiny — sourcing matters.

Brief Score

94/100

Updated August 2026

The ranking

Best GLP-1 providers, by Brief Score

Scored on six factors: price stability · supply reliability · transparency · access breadth · clinical oversight · track record, in Brief-Score order within each group. Desks we have a commercial relationship with are listed first; the score beside each name is ours and does not change because of it.

See the dedicated best GLP-1 providers ranking, the tirzepatide-only cheapest-tirzepatide tracker, the compounded-semaglutide desk list, or read the guides and head-to-head comparisons.

Lead story · #1 here

No. 1

Brief Score

94/100

Updated August 2026

Grade A

CoreAge Rx

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Semaglutide: $99/mo
Tirzepatide: $149/mo
Coverage: All 50 states
Price trend: Stableprice stable

Flat monthly price with no intro-rate step-up after month one — the most stable line on our tracker
Both compounded semaglutide and tirzepatide on one account
Available in all 50 states — the widest reliable footprint in the partner tier

Not the rock-bottom price — cheaper teaser tiers exist, but they don't hold
No FDA-approved brand-name option (compounded only)
Does not yet publicly name its 503A/B pharmacy partner

Visit CoreAge Rx Read the full brief →

No. 2

Brief Score

89/100

Updated August 2026

Grade B+

Trimi

A clean, all-in membership desk that publishes one price on both molecules nationwide and hasn't played the teaser-rate game.

Semaglutide: $175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge)
Tirzepatide: $235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge)
Coverage: All 50 states
Price trend: Stableprice stable

Both compounded semaglutide and tirzepatide disclosed up front — no quote-to-see-the-price wall
Flat membership rate held steady this cycle, with no month-one step-up
Available in all 50 states

Not the cheapest line in the ranking — several desks undercut its $196 semaglutide
Compounded only — no FDA-approved brand-name (Wegovy/Zepbound) route
No oral or sublingual option

Visit Trimi Read the full brief →

No. 4

Brief Score

87/100

Updated August 2026

Grade B+

Sesame Care

An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.

Semaglutide: Care $59/mo only on the 12-month prepay, otherwise $99 billed every 28 days (13 charges a year) — plus the drug: brand Wegovy pill from $149/mo at 1.5 and 4 mg only, $299/mo at 9 and 25 mg
Tirzepatide: Care $59/mo on the 12-month prepay, otherwise $99 per 28 days — plus the drug: brand Zepbound vial $299/mo (2.5 mg), $399 (5 mg), $449 (7.5–15 mg); KwikPen $299 / $399 / $499 / $699 (10–15 mg)
Coverage: Nationwide marketplace
Price trend: Stableprice stable

Real FDA-approved brand-name access — Wegovy pen and pill, Zepbound, Ozempic, Mounjaro and Rybelsus
Established platform (operating since 2018) with LegitScript, BBB accreditation and large third-party review volume
You choose the provider and see the price up front — genuine marketplace transparency

A generalist marketplace, not a dedicated weight-loss program — lighter ongoing hand-holding than a specialist desk
Two-part cost (a platform subscription plus the medication) makes the true monthly total harder to compare
Brand-name cash prices can run high without insurance

Visit Sesame Care Read the full brief →

No. 5

Brief Score

87/100

Updated August 2026

Grade B+

ShedRx

A weight-focused program with a low tracked tirzepatide rate and an oral/sublingual route for the needle-averse.

Semaglutide: $199/mo
Tirzepatide: $299/mo
Coverage: Not disclosed
Price trend: Fallingprice falling

Offers oral/sublingual forms — wider formulary than most
Low tracked tirzepatide price
Competitive on both molecules

States-served not disclosed
Compounded only

Visit ShedRx Read the full brief →

No. 6

Brief Score

86/100

Updated August 2026

Grade B

Sprout Health

A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.

Semaglutide: $299/mo
Tirzepatide: $349/mo
Coverage: Not disclosed
Price trend: Stableprice stable

LegitScript-certified with a listed address and contact line
Both compounded (from $299 semaglutide / $349 tirzepatide, with a $150-off first month) and a genuine brand-name Wegovy/Zepbound route
Low-friction intake — no labs and often no telehealth visit required

Compounded semaglutide and tirzepatide are not FDA-approved
No oral or sublingual route — injectable only
Thin transparency — no named medical director, and state availability is quiz-gated

FDA warning letter, September 2025 — issued to Sprout Health Partners LLC dba Sprout Health. See the FDA's warning letter database.

Visit Sprout Health Read the full brief →

No. 7

Brief Score

86/100

Updated August 2026

Grade B

HealthRX

A LegitScript-certified, physician-supervised desk (healthrx.com) whose real hook is breadth: injectable and a rare oral GLP tablet, on both molecules, with transparent no-insurance monthly pricing.

Semaglutide: $190/mo month-to-month ($99 first month, renews at $165) · $99/mo on a 12-month prepay ($1,188)
Tirzepatide: $239/mo month-to-month ($149 first month, renews at $214) · $179/mo on a 12-month prepay ($2,148)
Coverage: Not publicly listed
Price trend: Stableprice stable

LegitScript-certified (#50087439) — an independent trust signal most compounding desks lack
Physician-supervised telehealth with licensed-provider intake
Both molecules plus a rare oral GLP tablet — GLP injection ~$189/mo, oral ~$239/mo, GLP+GIP ~$349/mo

Core weight-loss product is compounded, which is not FDA-approved
Some tiers are company-stated on a thin public site, not checkout-verified
Brand tiers are pass-through — brand Ozempic runs ~$1,299/mo

Visit HealthRX Read the full brief →

No. 8

Brief Score

86/100

Updated August 2026

Grade B

MadeMed

Publishes a price for every dose of every route — which makes it easy to brief, and expensive if you stay low.

Semaglutide: $239/mo injectable · $219/mo sublingual (quarterly)
Tirzepatide: $399/mo injectable · $299/mo sublingual (quarterly)
Coverage: 40 states
Price trend: Stableprice stable

One published price per route that does not change as the dose climbs, so a titration schedule can be costed exactly
Sublingual tablets for BOTH molecules alongside the injections — a needle-free route at a lower price than the injection
Six-month plans drop the monthly rate below the quarterly headline

Flat-at-every-dose pricing means a reader holding a low dose pays the full-dose rate
Billed quarterly rather than monthly, so the real commitment is three months of cost up front
Available in 40 states rather than nationwide

Visit MadeMed Read the full brief →

No. 10

Brief Score

85/100

Updated August 2026

Grade B

Telos Rx

The widest published catalog in our ranking (telosrx.com): compounded semaglutide and tirzepatide in oral and microdosed forms, plus intranasal NAD+, recovery peptides and bioidentical HRT — all compounded, none FDA-approved, on a LegitScript-certified platform.

Semaglutide: $99/mo injectable — the $49 is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks
Tirzepatide: $139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide)
Coverage: Not publicly listed
Price trend: Stableprice stable

LegitScript-certified and HIPAA-compliant — a checkable trust signal most compounding desks lack
Deepest published menu we track — compounded semaglutide and tirzepatide alongside intranasal NAD+, recovery/GH peptides (sermorelin, ipamorelin, CJC-1295, BPC-157, TB-500) and bioidentical HRT
Genuinely needle-free options — oral semaglutide and tirzepatide, plus microdosed tirzepatide — for the injection-averse

Every line is compounded and not FDA-approved — including the peptides, several of which are research-grade with thin human evidence
⚠ The headline $49 and $99 are FIRST-MONTH rates that renew at $129 and $139, and the plans bill every 4, 12, 24 or 48 weeks rather than monthly — the "1-month" plan is 13 charges a year, not 12. Pricing outside GLP-1 stays opaque until intake
No named clinicians or leadership published, and only a thin base of public reviews

Visit Telos Rx Read the full brief →

That is the top 8 of 509 desks by Brief Score — the front page, not the whole edition. The full ranking goes deeper with a one-line wire table for the whole field, and every one of the other 501 has its own dispatch on the full index of every desk we track.

See the full ranking

Assume any provider we list may compensate us — see our disclosure. It never changes a Brief Score; it does move a desk up the listing order. Prices, states and verification reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on the provider's site. Not medical advice.

The 5-minute GLP-1 briefing — prices, shortages, and provider moves.

CoreAge Rx tops the ranking — $99/mo semaglutide, $149/mo tirzepatide.

Five ways to use this desk

Latest briefs

Flat-fee pricing holds while teaser tiers keep resetting

Both GLP-1 molecules stay off the FDA shortage list

Cheapest tracked tirzepatide slips again

A flat-fee pioneer drifts to the top of the price ranking

How we score a provider's price stability

The price tracker

Best GLP-1 providers, by Brief Score

CoreAge Rx

Trimi

Sesame Care

ShedRx

Sprout Health

HealthRX

MadeMed

Telos Rx